Google_______________

Risk Factors for Mother-to-child Transmission of Hepatitis C Virus

By Liz Highleyman

Hepatitis C virus (HCV) infection in children is mainly acquired via mother-to-child (perinatal) transmission. In a study published in the August 20,2007 issue of AIDS, French researchers sought to identify risk factors for mother-to-child HCV transmission, in particular those associated with maternal virological characteristics or mode of delivery.

The investigators included 214 HCV positive women and their newborn infants seen at 6 hospitals in southern France between October 1998 and September 2002. About one-quarter (55%) of the women were HIV-HCV coinfected. The authors collected data on maternal characteristics, circumstances of delivery, and laboratory data for the mothers and children. All babies were followed for 1 year, and those with detectable plasma HCV RNA for 2 years.

Results

In total, 12 infants had detectable HCV RNA at 1 year of age, yielding an overall mother-to-child transmission rate of 5.6%.

3 of these children became HCV RNA negative between 12 and 18 months of age and achieved normal alanine aminotransferase (ALT) levels.

137 women (69%) had detectable plasma HCV RNA, including all those whose children were infected.

6 children were born to HIV-HCV coinfected women with detectable HCV RNA, for a transmission rate of 13.6%.

6 were born to HCV monoinfected women with detectable HCV RNA, for a transmission rate of 6.5%.

The risk of mother-to-child HCV transmission was 3 times higher for HCV-HIV coinfected women compared to those with HCV alone (P = 0.05).

When maternal HCV RNA levels were below 6 log IU/ml, the rate of transmission was significantly higher in HIV-HCV coinfected women (odds ratio 8.3; P = 0.01.

This association with HIV status did not exist, however, for women with detectable HCV RNA levels of 6 log IU/ml or higher.

The rate of HCV transmission did not differ significantly between children born by vaginal delivery or Caesarean section after membrane rupture and those born by elective Caesarean section, independent of HIV status.

Conclusion

These findings confirm results of past studies showing that HIV-HCV coinfected women are more likely to transmit HCV to their babies than those with HCV alone. The study also confirmed that HCV viral load plays an important role in mother-to-child transmission/

Department of Public Health, France; CHU Nice, France; CHU Toulouse, France; CHU Montpellier, France; CHG Antibes, France; Virology Laboratory, France; INSERM U379, France.

08/21/07

Reference
E Marine-Barjoan, A Berrebi, V Giordanengo, and others (for the ALHICE study group). HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? AIDS 21(13): 1811-1815. August 20, 2007.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 




FDA-approved
Monotherapies for HCV
Intron A
Roferon

Infergen

Pegasys

PEG-Intron

FDA-approved
Combination
Therapies
for HCV
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin